Arca
Skip to content
Tools
Tools

ESRRG: Estrogen-related receptor gamma

Orphan receptor that acts as a transcription activator in the absence of bound ligand.

  • Drugs that act on it: 1
  • Approved: 0
  • In phases 1 to 3: 1
  • Sponsors: 1

Who is on it, and how far along

Every drug ChEMBL records acting on ESRRG, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 1

Approved0

    Phase 31

    • Afimoxifene

    Phase 20

      Phase 10

        The landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
        DrugFurthest stageSponsorModalityActionOpen trials
        AfimoxifenePhase 3Ascend Therapeutics USSmall moleculeAntagonistEstrogen-related receptor gamma antagonist1

        Open trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 1 in all, from ClinicalTrials.gov.
        TrialDrugPhaseStatusLead sponsorFirst posted
        Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One BreastAfimoxifenePhase 2Active, not recruitingNorthwestern UniversityJul 5, 2019

        Diseases most associated with it

        Open Targets association score, 0 to 1; all associations
        • Movement disorder0.47
        • Risk-taking behaviour0.43
        • Abnormality of the skeletal system0.41
        • Intelligence0.40
        • Refractive error0.37
        • Breast carcinoma0.36
        • Eye disorder0.35
        • Stroke disorder0.33

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL4245, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. Gene name, function (UniProt P62508, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

        Esc

        Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

        Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.